Compare Illumina, Inc. (ILMN) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Jones Lang LaSalle Inc — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Jones Lang LaSalle Inc trades at $364.99 (market cap $16.72B). The key difference: Illumina, Inc. is the larger of the two by market cap. Which is the better fit depends on your goals.
| ILMN | JLL | |
|---|---|---|
Market Cap | $29.12B | $16.72B |
Sector | Health | Real Estate |
52-Week High | $205.10 | $373.24 |
52-Week Low | $91.00 | $280.16 |
Enterprise Value | $30.48B | $19.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
